126 related articles for article (PubMed ID: 34819239)
21. The Psychometric Properties of the Voice Handicap Index in People With Parkinson's Disease.
Guimaraes I; Cardoso R; Pinto S; Ferreira JJ
J Voice; 2017 Mar; 31(2):258.e13-258.e18. PubMed ID: 27397112
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of vocal symptoms in Parkinson's disease: the Lee Silverman method].
Dias AE; Limongi JC
Arq Neuropsiquiatr; 2003 Mar; 61(1):61-6. PubMed ID: 12715021
[TBL] [Abstract][Full Text] [Related]
23. Objective and Subjective Aspects of Voice in Pregnancy.
Saltürk Z; Kumral TL; Bekiten G; Atar Y; Ataç E; Aydoğdu İ; Yıldırım G; Kılıç A; Uyar Y
J Voice; 2016 Jan; 30(1):70-3. PubMed ID: 25913751
[TBL] [Abstract][Full Text] [Related]
24. Do I sound dry? Comparative voice analysis of primary Sjögren's syndrome.
Kim SY; Lee J; Choi YS; Kim JW; Kwok SK; Park YH; Sun DI; Park SH
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):130-136. PubMed ID: 30156538
[TBL] [Abstract][Full Text] [Related]
25. Natural Voice Use in Patients With Voice Disorders and Vocally Healthy Speakers Based on 2 Days Voice Accumulator Information From a Database.
Södersten M; Salomão GL; McAllister A; Ternström S
J Voice; 2015 Sep; 29(5):646.e1-9. PubMed ID: 26073776
[TBL] [Abstract][Full Text] [Related]
26. Survey of Voice Acoustic Parameters in Iranian Female Teachers.
Mohseni R; Sandoughdar N
J Voice; 2016 Jul; 30(4):507.e1-5. PubMed ID: 26275636
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes of PD Check-In, a model for supported self-managed maintenance of speech in Parkinson's disease: A Phase 1 study.
Finnimore A; Theodoros D; Rumbach AF
Int J Lang Commun Disord; 2023 Mar; 58(2):241-255. PubMed ID: 36036751
[TBL] [Abstract][Full Text] [Related]
28. Motor-Learning-Based Adjustment of Ambulatory Feedback on Vocal Loudness for Patients With Parkinson's Disease.
Gustafsson J; Ternström S; Södersten M; Schalling E
J Voice; 2016 Jul; 30(4):407-15. PubMed ID: 26168903
[TBL] [Abstract][Full Text] [Related]
29. Task-based profile of vocal intensity decline in Parkinson's disease.
Rosen KM; Kent RD; Duffy JR
Folia Phoniatr Logop; 2005; 57(1):28-37. PubMed ID: 15655339
[TBL] [Abstract][Full Text] [Related]
30. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
[TBL] [Abstract][Full Text] [Related]
31. Aerodynamic measurements of patients with Parkinson's disease.
Jiang J; O'Mara T; Chen HJ; Stern JI; Vlagos D; Hanson D
J Voice; 1999 Dec; 13(4):583-91. PubMed ID: 10622523
[TBL] [Abstract][Full Text] [Related]
32. Subjective and objective voice evaluation in Sjögren's syndrome.
Saltürk Z; Özdemir E; Kumral TL; Karabacakoğlu Z; Kumral E; Yildiz HE; Mersinlioğlu G; Atar Y; Berkiten G; Yildirim G; Uyar Y
Logoped Phoniatr Vocol; 2017 Apr; 42(1):9-11. PubMed ID: 26634781
[TBL] [Abstract][Full Text] [Related]
33. Assessing disordered speech and voice in Parkinson's disease: a telerehabilitation application.
Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
Int J Lang Commun Disord; 2010; 45(6):630-44. PubMed ID: 20102257
[TBL] [Abstract][Full Text] [Related]
34. Voice Quality as Therapeutic Outcome in Laryngopharyngeal Reflux Disease: A Prospective Cohort Study.
Lechien JR; Finck C; Huet K; Fourneau AF; Khalife M; Delvaux V; Piccaluga M; Harmegnies B; Saussez S
J Voice; 2020 Jan; 34(1):112-120. PubMed ID: 30220528
[TBL] [Abstract][Full Text] [Related]
35. An Efficacy Study of Voice Quality Using Cepstral Analyses of Phonation in Parkinson's Disease before and after SPEAK-OUT!®.
Boutsen FR; Park E; Dvorak JD
Folia Phoniatr Logop; 2023; 75(1):35-42. PubMed ID: 35817007
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Hypophonia in Parkinson's Disease Through Biofeedback in Daily Life Administered with A Portable Voice Accumulator.
Gustafsson JK; Södersten M; Ternström S; Schalling E
J Voice; 2024 May; 38(3):800.e27-800.e38. PubMed ID: 34893384
[TBL] [Abstract][Full Text] [Related]
37. Objective acoustic quantification of phonatory dysfunction in Huntington's disease.
Rusz J; Klempíř J; Baborová E; Tykalová T; Majerová V; Cmejla R; Růžička E; Roth J
PLoS One; 2013; 8(6):e65881. PubMed ID: 23762447
[TBL] [Abstract][Full Text] [Related]
38. Gender-specific vocal dysfunctions in Parkinson's disease: electroglottographic and acoustic analyses.
Hertrich I; Ackermann H
Ann Otol Rhinol Laryngol; 1995 Mar; 104(3):197-202. PubMed ID: 7872602
[TBL] [Abstract][Full Text] [Related]
39. Voice Therapy Effect on Mutational Falsetto Patients: A Vocal Aerodynamic Study.
Liang FY; Huang XM; Chen L; Huang YZ; Zhang XY; Su JH; Wang YJ; Yang JS; Zheng YQ; Mei XS; Guan Z
J Voice; 2017 Jan; 31(1):114.e1-114.e5. PubMed ID: 27589888
[TBL] [Abstract][Full Text] [Related]
40. A quantitative method for the assessment of dysarthrophonia in myasthenia gravis.
Konstantopoulos K; Christou YP; Vogazianos P; Zamba-Papanicolaou E; Kleopa KA
J Neurol Sci; 2017 Jun; 377():42-46. PubMed ID: 28477705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
